Amitiza FDA Approved Drugs
AMITIZA [LubiprostoneC20H32F2O5]
RX
- 24mcg (oral capsule)
8mcg (oral capsule)
Sucampo Pharma LlcJan 31, 2006
- Method for relieving constipation in a human patient that comprises administering to the patient a dosage unit comprising (i) 24mcg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient.
- Method for relieving constipation in a patient with opioid-induced constipation that comprises administering to the patient a dosage unit comprising(i)24microg+/- 10% of a drug substance and (ii) a pharmaceutically suitable excipient.
- Method for relieving or treating constipation in a human constipated patient.
- Method for relieving or treating constipation in a patient with irritable bowel syndrome.
- Method for relieving or treating constipation in a patient with opioid-induced constipation.
- Method for the long term treatment of chronic constipation in a human subject with irritable bowel syndrome.
- Method for the long term treatment of chronic constipation in a human subject.
- Method for treating constipation by opening cic channels in a mammalian subject.
- Method for treating constipation in a patient with opioid-induced constipation by opening cic channels.
- Method for treating irritable bowel syndrome and method for treating abdominal discomfort associated with irritable bowel syndrome.
- Method for treating opioid-induced constipation.
- Method of relieving or preventing constipation in a human constipated patient.
- Method of relieving or preventing constipation in a human patient with opioid-induced constipation.
- Method of treating constipation in a patient with irritable bowel syndrome by opening chloride channels (cic).
- Method of treating constipation in a patient with irritable bowel syndrome.
- Use in relieving or preventing constipation in a human patient with a dosage unit comprising 24microg+/- 10% of a drug substance and a pharmaceutically suitable excipient.
- Use in relieving or preventing constipation in a patient with opioid-induced constipation with a dosage unit comprising 24microg +/- 10% of a drug substance and a pharmaceutically suitable excipient.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.